thiazoles has been researched along with Carcinoma, Ductal, Breast in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Corbaux, P; Sabatier, R | 1 |
Choi, J; Han, D; Hwang, EH; Im, SA; Kang, SE; Kim, K; Lee, H; Lee, KH; Lee, KM; Moon, WK; Oh, HJ; Ryu, HS | 1 |
Matthews, EK; Ward, AJ | 1 |
Grisé, KR; Laird, EC; McFadden, DW; Rongione, AJ | 1 |
Heisler, T; McFadden, DW; Simon, N; Towfigh, S | 1 |
Djiane, J; Gourdou, I; Laud, K; Pessemesse, L; Peyrat, JP | 1 |
6 other study(ies) available for thiazoles and Carcinoma, Ductal, Breast
Article | Year |
---|---|
[New European approvals: Alpelisib for HRpos/HER2neg metastatic breast cancer with PIK3CA mutation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Class I Phosphatidylinositol 3-Kinases; Clinical Trials as Topic; Drug Approval; Drug Resistance, Neoplasm; Estrogens; Female; Fulvestrant; Humans; Male; Multicenter Studies as Topic; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Progesterone; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Thiazoles | 2020 |
Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancer.
Topics: Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; Biopsy; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Clinical Decision-Making; Drug Synergism; Female; Humans; Mastectomy; Mitochondrial Proteins; Necroptosis; Neoadjuvant Therapy; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiazoles; Tyrosine-tRNA Ligase | 2020 |
Cytotoxic, nuclear, and growth inhibitory effects of photodynamic drugs on pancreatic carcinoma cells.
Topics: Animals; Carcinoma, Ductal, Breast; Cell Division; Cell Survival; Cricetinae; DNA, Neoplasm; Indoles; Mesocricetus; Micronuclei, Chromosome-Defective; Micronucleus Tests; Organometallic Compounds; Pancreatic Neoplasms; Photochemotherapy; Porphyrins; Radiation-Sensitizing Agents; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1996 |
Peptide YY inhibits growth of human breast cancer in vitro and in vivo.
Topics: Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Cell Survival; Coloring Agents; Cyclic AMP; Female; Humans; Intracellular Membranes; Mice; Mice, Nude; Peptide YY; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1999 |
Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Cell Survival; Coloring Agents; Female; Humans; Peptide YY; Receptors, Estrogen; Tetrazolium Salts; Thiazoles; Tocopherols; Tumor Cells, Cultured; Vitamin E | 2000 |
Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line.
Topics: Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Carrier Proteins; Cell Division; DNA Primers; Female; Humans; In Situ Hybridization; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Cell Surface; Receptors, Leptin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Thymidine; Tumor Cells, Cultured | 2002 |